CD5 and B-cell chronic lymphocytic leukemia: The constitutive activation of Lyn leads to the phosphorylation of the immunoreceptor tyrosine inhibitory motifs (ITIMs) in CD5 inhibitory coreceptors, which are aberrantly expressed on B‐CLL cells.